1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow LAS190792 Dose 5: new trials by email Literature Review of LAS190792 Dose 5 trials Research Report on LAS190792 Dose 5
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD LAS190792 Dose 1, LAS190792 Dose 2, LAS190792 Dose 3 - Chronic Obstructive Pulmonary Disease (COPD), Asthma | Phase 1 | Completed | AstraZeneca | 55 | 2013-09-01 | 2019-06-21 |
Asthma (1) · Pulmonary Disease, Chronic Obstructive (1)
AstraZeneca (1)
United Kingdom (1)